2024 BioMAN Summit
Artificial Intelligence(AI); including techniques such as machine learning (ML), deep learning (DL), and natural language processing (NLP); has the potential to transform the way biologic medicines are manufactured. FDA reported that in 2021 alone, over 100 new drug and biologic license application submissions contained the use of AI and ML, with the areas of AI/ML applications panning the entire product development pipeline, from drug development to post-market surveillance. While FDA continues to develop the regulatory framework for using AI in biomanufacturing, industry must itself prepare their organizations to take advantage of the opportunities presented by these new tools.
As AI applications become more common in biological drug manufacturing, it will also be critically important to ensure that this new technology is being applied correctly by a well-trained workforce, especially as it is used in novel indications.
MIT’s Center for Biomedical Innovation will host the 2024 BioMAN Summit, which brings together thought leaders from industry, academia, and government for a series of invited presentations to investigate:
Application
How are AI and its associated techniques currently being used in biomanufacturing?
Challenges
What have been the main challenges to implementing AI and ML, and how has the industry overcome them?
Future
What are the most promising future applications of AI in biomanufacturing in both the near and long terms?
Workforce
How can the industry ensure there is a well-trained AI workforce that is integrated into manufacturing operations?
Regulation
How are regulatory and industry bodies supporting AI in biomanufacturing and what opportunities remain for increased cooperation?
Keynote Speakers
Pablo Rolandi
Executive Director, Process Development
Amgen
Raghu Shivappa
Vice President, Global Biologics and Gene Therapy Process Development
Takeda
Richard Braatz
Edwin R. Gilliland Professor; Professor of Chemical Engineering
MIT
Speakers
George Barbastathis
Professor, Mechanical Engineering
MIT
Amos Lu
Data Scientist
Sanofi
Vikram Agarwal
Head, mRNA Platform Design Data Science mRNA Center of Excellence
Sanofi
Eranda Harinath
Principal Scientist, mRNA Platform Design Data Science mRNA Center of Excellence
Sanofi
Melissa St. Amand
Global Head of MSAT Digital Transformation
Sanofi
Joseph Thangraj
Senior Data Scientist
Sanofi
Veera Padmanabhan
Global Biopharmaceutical Operations Executive
AstraZeneca
Preeya Boppana
Director, MS&T Process Analytics and Laboratories
AstraZeneca
Reza Kamyar
Director, AI & Advanced Control Pfizer
Timo Schmidberger
Principal Data Scientist
Sartorius
Retsef Levi
J. Spencer Standish (1945) Professor of Management
MIT
PROGRAM
REGISTRATION
The deadline for the Summit registration is November 5th!
Please reach out to Lola Atitebi if you are interested in receiving applicable member discount rates or other pricing questions.
Venue
The Summit will be held in Building E14, 75 Amherst St, Cambridge, MA 02139
Sponsors
The Summit is made possible by our BioMAN Consortium Members: